BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/22/2014 7:36:00 PM | Browse: 1364 | Download: 1544
 |
Received |
|
2013-12-28 14:52 |
|
Peer-Review Started |
|
2013-12-28 19:31 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2014-03-28 14:19 |
|
Revised |
|
2014-04-24 18:04 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2014-05-29 16:45 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2014-05-29 17:04 |
|
Articles in Press |
|
2014-05-29 17:23 |
|
Edit the Manuscript by Language Editor |
|
2014-06-13 16:00 |
|
Typeset the Manuscript |
|
2014-08-05 18:41 |
|
Publish the Manuscript Online |
|
2014-08-17 13:16 |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Review |
| Article Title |
Targeting inflammation in diabetes: Newer therapeutic options
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Neeraj Kumar Agrawal and Saket Kant |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Dr. Neeraj Kumar Agrawal, Associate Professor, Department of Endocrinology and Metabolism, Institiute of Medical Sciences, Banaras Hindu University, Pandit Madan Mohan Malviya Rd, Varanasi 221005, India. drnkavns@gmail.com |
| Key Words |
Inflammation; Insulin resistance; Diabetes; Neuropathy; Retinopathy; Nephropathy |
| Core Tip |
The burden of diabetes and its complications is increasing worldwide. To control this pandemic, drugs targeting different areas of the pathogenesis of diabetes and its complications are needed. Inflammation plays a key role in the natural history of diabetes during the progression from pre-diabetes to diabetes, including decreased beta cell secretory capacity and insulin resistance. Insulin resistance is an important part of the metabolic syndrome and plays a role in the pathogenesis of various macrovascular complications. Drugs targeting inflammatory pathways represent a fresh approach in the treatment of diabetes and its complications. |
| Publish Date |
2014-08-17 13:16 |
| Citation |
Agrawal NK, Kant S. Targeting inflammation in diabetes: Newer therapeutic options. World J Diabetes 2014; 5(5): 697-710
|
| URL |
http://www.wjgnet.com/1948-9358/full/v5/i5/697.htm |
| DOI |
http://dx.doi.org/10.4239/wjd.v5.i5.697 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
